Clinical Utility of Anti-CADM-140/Melanoma Differentiation-Associated Gene 5 Autoantibody Titers in Patients with Juvenile Dermatomyositis and Rapidly Progressive Interstitial Lung Disease

被引：0
|
作者：
Sato, Shinji [1 ]
Kobayashi, Norimoto [2 ]
Yamazaki, Kazuko [3 ]
Suzuki, Yasuo [1 ]
机构：
[1] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan
[2] Shinshu Univ, Sch Med, Matsumoto, Nagano 390, Japan
[3] Yokohama City Univ Med, Yokohama, Kanagawa, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
292
引用
收藏
页码：S128 / S128
页数：1
相关论文
共 50 条
  • [21] Clinical features and prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease in Chinese patients
    Lian, Li
    Tong, Jing-jing
    Xu, Sheng-qian
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (06)
  • [22] Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis
    So, Jacqueline
    So, Ho
    Wong, Victor Tak-Lung
    Ho, Roy
    Wu, Tsz Yuen
    Wong, Priscilla Ching-Han
    Tam, Lydia Ho-Pui
    Ho, Chi
    Lam, Tommy Tsz-On
    Chung, Yuen Kwan
    Li, Wai Ling
    To, Chi Hung
    Lau, Chak Sing
    Mok, Chi Chiu
    Tam, Lai-Shan
    RHEUMATOLOGY, 2022, 61 (11) : 4437 - 4444
  • [23] A Rare Pediatric Case of Anti-melanoma Differentiation-associated Gene 5 Rapidly Progressive Interstitial Lung Disease
    Gallagher, K.
    Ortenberg, R.
    Toprak, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [24] The Clinical Features of Recurrent Interstitial Lung Disease in Dermatomyositis Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody
    Hosono, Yuji
    Nakashima, Ran
    Murakami, Kosaku
    Imura, Yoshitaka
    Yukawa, Naoichiro
    Yoshifuji, Hajime
    Ohmura, Koichiro
    Mimori, Tsuneyo
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [25] Predictors of Rapidly Progressive Interstitial Lung Disease and Mortality in Patients with Autoantibodies Against Melanoma Differentiation-Associated Protein 5 Dermatomyositis
    So, Jacqueline
    Tam, Lai-Shan
    Wong, Priscilla
    Tam, Lydia Ho-Pui
    Lam, Tsz On
    Mok, Chi Chiu
    To, Chi Hung
    Chung, Yuen Kwan
    Wong, Victor Tak Lung
    Wu, Tsz Yuen
    Ho, Roy
    Li, Wai Ling
    Ho, Chi
    So, Ho
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1384 - 1386
  • [26] A RARE CASE OF RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN A PATIENT WITH CLINICALLY AMYOPATHIC DERMATOMYOSITIS WITH ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 ANTIBODIES
    Mahajan, Pranav
    Upadhyay, Riddhi
    Aedma, Surya
    Khan, Muhammad Talha
    Thameem, Danish
    CHEST, 2020, 158 (04) : 1165A - 1166A
  • [27] Progranulin correlated with rapid progressive interstitial lung disease in dermatomyositis with anti-melanoma differentiation-associated gene 5 antibody
    Shanshan, Li
    Yamei, Zhang
    Ling, Zhang
    Xin, Lu
    Guochun, Wang
    CLINICAL RHEUMATOLOGY, 2022, 41 (03) : 757 - 763
  • [28] Progranulin correlated with rapid progressive interstitial lung disease in dermatomyositis with anti-melanoma differentiation-associated gene 5 antibody
    Li Shanshan
    Zhang Yamei
    Zhang Ling
    Lu Xin
    Wang Guochun
    Clinical Rheumatology, 2022, 41 : 757 - 763
  • [29] Anti-melanoma differentiation-associated gene 5 dermatomyositis and lung disease
    Miyagami, T.
    Suyama, Y.
    Takahashi, Y.
    Yahagi, Y.
    Harada, M.
    Sugisaki, N.
    Matsudaira, R.
    Kanai, Y.
    Yang, K-S
    Naito, T.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (11) : 832 - 833
  • [30] Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis
    Moghadam-Kia, Siamak
    Oddis, Chester V.
    Sato, Shinji
    Kuwana, Masataka
    Aggarwal, Rohit
    ARTHRITIS CARE & RESEARCH, 2016, 68 (05) : 689 - 694
12345